Jin‐Guang Yao

Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study

Marianne Pavel, Éric Baudin, Kjell E. Öberg et al. · Annals of Oncology · 2017 · 120 citations · Full text

Medicine, Oncology, Pharmacology +17

A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial

Matthew H. Kulke, Philippe Ruszniewski, Eric Van Cutsem et al. · Annals of Oncology · 2017 · 104 citations · Full text

Medicine, Endocrinology, Oncology +15

MicroRNA-24 Modulates Aflatoxin B1-Related Hepatocellular Carcinoma Prognosis and Tumorigenesis

Yixiao Liu, Xi‐Dai Long, Zhifeng Xi et al. · BioMed Research International · 2014 · 75 citations · Full text

Medicine, Oncology, Pathology +17

Genetic Polymorphisms in DNA Repair Genes XRCC4 and XRCC5 and Aflatoxin B1–related Hepatocellular Carcinoma

Xi‐Dai Long, Dong Zhao, Chao Wang et al. · Epidemiology · 2013 · 74 citations

Medicine, Genetics, Oncology +13

MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis

Xiao‐Ying Huang, Jin‐Guang Yao, Hongdong Huang et al. · Gastroenterology Research and Practice · 2013 · 54 citations · Full text

Medicine, Cancer Biology, Oncology +17